Judge rejects Donald Trump bid to dismiss E. Jean Carroll’s first defamation lawsuit

By Jonathan Stempel NEW YORK (Reuters) -A federal judge on Thursday rejected Donald Trump’s bid to dismiss the first of writer E. Jean Carroll’s two lawsuits accusing the former U.S. president of defamation for denying he raped her in the mid-1990s. U.S. District Judge Lewis Kaplan in Manhattan found no merit in Trump’s arguments that…

Read More

Exclusive-Trump, longtime admirer of Putin, says aborted mutiny ‘somewhat weakened’ Russian leader

By Steve Holland and Nathan Layne WASHINGTON (Reuters) – Former U.S. President Donald Trump, a longtime admirer of Russian President Vladimir Putin, said on Thursday Putin has been “somewhat weakened” by an aborted mutiny and that now is the time for the United States to try to broker a negotiated peace settlement between Russia and…

Read More

US lawmaker urges labelling, restrictions on AI content

WASHINGTON (Reuters) – U.S. Senator Michael Bennet, a Democrat who is active in artificial-intelligence issues, wrote to leading tech firms on Thursday to urge them to label AI-generated content and limit the spread of material aimed at misleading users. In the letter to the chief executives of OpenAI, which released ChatGPT, and its partner Microsoft…

Read More

IMF board completes Ukraine loan review, allowing $890 million withdrawal

By David Lawder and Andrea Shalal WASHINGTON (Reuters) -The International Monetary Fund’s executive board on Thursday completed its first review of Ukraine’s $15.6 billion loan program, allowing Kyiv to immediately withdraw $890 million for budget support as it mounts a major offensive against Russia’s invasion. The board’s approval brings Ukraine’s withdrawals under the program launched…

Read More

Hold the Ozempic before surgery, US doctors say

By Julie Steenhuysen CHICAGO (Reuters) – People taking popular diabetes and weight loss drugs such as Novo Nordisk’s Ozempic and Wegovy or Eli Lilly’s Mounjaro should temporarily stop taking them before having elective surgery to avoid possible serious complications, the American Society of Anesthesiologists (ASA) said on Thursday. The group has received anecdotal reports from…

Read More

US FDA approves BioMarin’s gene therapy for hemophilia A

By Nathan Gomes (Reuters) -The U.S. Food and Drug Administration on Thursday approved BioMarin Pharmaceutical’s gene therapy for severe hemophilia A, the company said, giving patients with the inherited bleeding disorder an alternative to regular injections of missing blood proteins. It priced the one-time therapy, Roctavian, at $2.9 million. Pivotal trial results showed that Roctavian…

Read More